Gonadal hormones decrease temporomandibular joint κ-mediated antinociception through a down-regulation in the expression of kappa opioid receptors in the trigeminal ganglia

European Journal of Pharmacology

Volumn 617, Issue 1-3, 2009, Pages 41-47

  Clemente Napimoga, Juliana T ^a,b   Pellegrini da Silva, Adriana ^a   Ferreira, Vinícius H A ^a   Napimoga, Marcelo H ^b   Parada, Carlos A ^c   Tambeli, Cláudia H ^a  

^a Piracicaba Dental School   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Estrous cycle; Kappa opioid receptor; L Arginine NO cGMP pathway; Nociception; Sex difference; Temporomandibular joint

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ARGININE; CYCLIC GMP; ESTRADIOL; GUANYLATE CYCLASE INHIBITOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIESTRUS; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MALE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; PROESTRUS; PROTEIN EXPRESSION; RAT; TEMPOROMANDIBULAR JOINT; TRIGEMINUS GANGLION; WESTERN BLOTTING;

ANALGESICS; ANIMALS; ARGININE; CYCLIC GMP; DOWN-REGULATION; FEMALE; GONADAL HORMONES; HUMANS; MALE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXADIAZOLES; PAIN; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT; TRIGEMINAL GANGLION;

EID: 68549115151     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.036     Document Type: Article

References (40)

1. Amarante L.H., Alves D.P., and Duarte I.D. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. Eur. J. Pharmacol 494 (2004) 155-160
2. Amarante L.H., and Duarte I.D. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the l-arginine/nitric oxide/cyclic GMP pathway. Eur. J. Pharmacol 454 (2002) 19-23
3. Bereiter D.A. Sex differences in brainstem neural activation after injury to the TMJ region. Cells Tissues Organs 169 (2001) 226-237
4. Bi J., Hu X., Loh H.H., and Wei L.N. Mouse kappa-opioid receptor mRNA differential transport in neurons. Mol. Pharmacol 64 (2003) 594-599
5. Binder W., Carmody J., and Walker J. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. J. Pharmacol. Exp. Ther 292 (2000) 303-309
6. Butcher R.L., Collins W.E., and Fugo N.W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94 (1974) 1704-1708
7. Chang P.C., Aicher S.A., and Drake C.T. Kappa opioid receptors in rat spinal cord vary across the estrous cycle. Brain Res 861 (2000) 168-172
8. Clemente J.T., Parada C.A., Veiga M.C., Gear R.W., and Tambeli C.H. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci. Lett 372 (2004) 250-255
9. Drake C.T., De Oliveira A.X., Harris J.A., Connor D.M., Winkler C.W., and Aicher S.A. Kappa opioid receptors in the rostral ventromedial medulla of male and female rats. J. Comp. Neurol 500 (2007) 465-476
10. Fischer, L., Clemente, J.T., Tambeli, C.H., 2007. The protective role of testosterone in the development of temporomandibular joint pain. J Pain 8, 437-442.
11. Fischer L., Torres-Chávez K.E., Clemente-Napimoga J.T., Jorge D., Arsati F., de Arruda Veiga M.C., and Tambeli C.H. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats J. Pain 9 (2008) 630-638
12. Gear R.W., Gordon N.C., Heller P.H., Paul S., Miaskowski C., and Levine J.D. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci. Lett 205 (1996) 207-209
13. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., and Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat. Med 2 (1996) 1248-1250
14. Haas D.A., Nakanishi O., MacMillan R.E., Jordan R.C., and Hu J.W. Development of an orofacial model of acute inflammation in the rat. Arch. Oral Biol 37 (1992) 417-422
15. Hu J.W. Response properties of nociceptive and non-nociceptive neurons in the rat's trigeminal subnucleus caudalis (medullary dorsal horn) related to cutaneous and deep craniofacial afferent stimulation and modulation by diffuse noxious inhibitory controls. Pain 41 (1990) 331-345
16. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod 72 (2005) 1290-1296
17. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., and Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci 15 (1995) 8156-8166
18. Lefkowitz R.J. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem 273 (1998) 18677-18680
19. Kalyuzhny A., Lee N.M., and Elde R. An opioid binding protein is specifically down-regulated by chronic morphine treatment in dorsal root and trigeminal ganglia. Neuroscience 66 (1995) 943-949
20. LeResche L., Saunders K., Von Korff M.R., Barlow W., and Dworkin S.F. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 69 (1997) 153-160
21. Maggi R., Ma Z.Q., Pimpinelli F., Maggi A., and Martini L. Decrease of the number of opioid receptors and of the responsiveness to morphineduring neuronal differentiation induced by 17beta-estradiol in estrogen receptor-transfected neuroblastoma cells (SK-ER3). Neuroendocrinology 69 (1999) 54-62
22. Morelli A., Filippi S., Zhang X.H., Luconi M., Vignozzi L., Mancina R., and Maggi M. Peripheral regulatory mechanisms in erection. Int. J. Androl 28 (2005) 23-27
23. Nozaki-Taguchi N., and Yamamoto T. Involvement of nitric oxide in peripheral antinociception mediated by kappa- and delta-opioid receptors. Anesth. Analg 87 (1998) 388-393
24. Picolo G., Cassola A.C., and Cury Y. Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol 469 (2003) 57-64
25. Puri V., Chandrala S., Puri S., Daniel C.G., Klein R.M., and Berman N.E. Ghrelin is expressed in trigeminal neurons of female mice in phase with the estrous cycle. Neuropeptides 40 (2006) 35-46
26. Puri V., Cui L., Liverman C.S., Roby K.F., Klein R.M., Welch K.M., and Berman N.E. Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides 39 (2005) 409-417
27. Rau K.K., Caudle R.M., Cooper B.Y., and Johnson R.D. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. J. Chem. Neuroanat 29 (2005) 255-264
28. Rodrigues A.R.A., and Duarte I.D.G. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K+ channels. Br. J. Pharmacol 129, 110- 114 (2000)
29. Rosland J.H. The formalin test in mice: the influence of ambient temperature. Pain 45 (1991) 211-216
30. Roveroni R.C., Parada C.A., Veiga M.C.F.Q., and Tambeli C.H. Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain 94 (2001) 185-191
31. Shen P.J., Smith A.I., Evans R.G., and Clarke I.J. Effects of ovarian steroids on hypothalamic opioid receptor subtypes in ovariectomized ewes: regional changes in density and affinity. J. Endocrinol 145 (1995) 559-567
32. Smith M.S., Freeman M.E., and Neill J.D. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96 (1975) 219-226
33. Soares A.C., Leite R., Tatsuo M.A., and Duarte I.D. Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol 400 (2000) 67-71
34. Tershner S.A., Mitchell J.M., and Fields H.L. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain 85 (2000) 153-159
35. Warren M.P., and Fried J.L. Temporomandibular disorders and hormones in women. Cells Tissues Organs 169 (2001) 187-192
36. Waynforth H., and Flecknell P. Experimental and Surgical Technique in the Rat. 2nd ed (1992), Academic Press, London
37. Weiland N.G., and Wise P.M. Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology 126 (1990) 804-808
38. Xie G.X., Meuser T., Pietruck C., Sharma M., and Palmer P.P. Presence of opioid receptor-like (ORL1) receptor mRNA splice variants in peripheral sensory and sympathetic neuronal ganglia. Life Sci 64 (1999) 2029-2037
39. Yallampalli C., Byam-Smith M., Nelson S.O., and Garfield R.E. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 134 (1994) 1971-1974
40. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110